Spectaire (SPEC) Competitors $0.0002 0.00 (-81.82%) As of 07/7/2025 10:10 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsTrendsBuy This Stock SPEC vs. THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, VLTO, and FTVShould you be buying Spectaire stock or one of its competitors? The main competitors of Spectaire include ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Veralto (VLTO), and Fortive (FTV). These companies are all part of the "measuring and control equipment" industry. Spectaire vs. Its Competitors ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Veralto Fortive Spectaire (NASDAQ:SPEC) and ThermoGenesis (NASDAQ:THMO) are both small-cap measuring and control equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings. Which has more volatility and risk, SPEC or THMO? Spectaire has a beta of -6.38, suggesting that its share price is 738% less volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Is SPEC or THMO more profitable? ThermoGenesis' return on equity of 0.00% beat Spectaire's return on equity.Company Net Margins Return on Equity Return on Assets SpectaireN/A -81.22% 304.57% ThermoGenesis N/A N/A N/A Does the media favor SPEC or THMO? In the previous week, Spectaire's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score. Company Overall Sentiment Spectaire Neutral ThermoGenesis Neutral Which has preferable valuation & earnings, SPEC or THMO? Spectaire has higher earnings, but lower revenue than ThermoGenesis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectaireN/AN/A$8.95MN/AN/AThermoGenesis$9.61M0.00-$17.98M-$5.14N/A Do insiders & institutionals have more ownership in SPEC or THMO? 26.5% of Spectaire shares are held by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are held by institutional investors. 25.4% of Spectaire shares are held by insiders. Comparatively, 78.0% of ThermoGenesis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryThermoGenesis beats Spectaire on 4 of the 7 factors compared between the two stocks. Get Spectaire News Delivered to You Automatically Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPEC vs. The Competition Export to ExcelMetricSpectaireMeasuring & controlling devices IndustryComputer SectorNASDAQ ExchangeMarket Cap$4K$36.05M$27.32B$8.92BDividend YieldN/A8.00%3.12%4.04%P/E RatioN/A4.2137.0920.12Price / SalesN/A3.461,952.1993.35Price / CashN/A8.3834.7728.59Price / Book0.001.797.185.57Net Income$8.95M$7.16M$763.56M$248.40M7 Day PerformanceN/A2.95%2.13%6.04%1 Month PerformanceN/A19.83%5.72%7.69%1 Year PerformanceN/A13.20%52,367.21%20.97% Spectaire Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPECSpectaireN/A$0.00-81.8%N/A-100.0%$4KN/A0.008Gap UpTHMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/A$0.00flatN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.09flatN/A-30.0%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.04-1.8%N/A+272.2%$0.00$41.52M0.001Positive NewsQSIAWQuantum-SiN/A$0.63-10.6%N/A+353.8%$0.00$3.44M0.00150SMAPWSportsMap Tech AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/ATTTrane Technologies4.3257 of 5 stars$430.92-0.7%$430.13-0.2%+30.9%$96.13B$19.84B35.8645,000Positive NewsAnalyst ForecastKEYSKeysight Technologies4.1862 of 5 stars$164.85+0.2%$183.00+11.0%+18.3%$28.38B$4.98B38.7115,500Positive NewsVLTOVeralto3.1361 of 5 stars$102.95+0.3%$110.09+6.9%+7.4%$25.51B$5.19B29.4117,000News CoveragePositive NewsFTVFortive4.9209 of 5 stars$53.46+0.6%$77.08+44.2%-26.8%$18.17B$6.23B23.4518,000Analyst Upgrade Related Companies and Tools Related Companies THMO Alternatives HTGMQ Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives SMAPW Alternatives TT Alternatives KEYS Alternatives VLTO Alternatives FTV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SPEC) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectaire Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectaire With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPEC Stock Alerts